Skip to main page content
Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

My NCBI Filters
Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
1957 1
1958 1
1959 1
1960 1
1961 3
1962 2
1963 7
1964 7
1965 9
1966 12
1967 16
1968 10
1969 10
1970 12
1971 10
1972 11
1973 12
1974 23
1975 17
1976 14
1977 21
1978 18
1979 21
1980 23
1981 29
1982 26
1983 26
1984 35
1985 37
1986 48
1987 38
1988 38
1989 49
1990 62
1991 58
1992 71
1993 81
1994 73
1995 77
1996 83
1997 94
1998 107
1999 111
2000 133
2001 121
2002 130
2003 133
2004 126
2005 147
2006 149
2007 149
2008 156
2009 164
2010 173
2011 214
2012 202
2013 197
2014 226
2015 203
2016 224
2017 246
2018 266
2019 318
2020 337
2021 331
2022 155
Text availability
Article attribute
Article type
Publication date

Search Results

5,429 results
Results by year
Filters applied: . Clear all
Page 1
In vivo CRISPR base editing of PCSK9 durably lowers cholesterol in primates.
Musunuru K, Chadwick AC, Mizoguchi T, Garcia SP, DeNizio JE, Reiss CW, Wang K, Iyer S, Dutta C, Clendaniel V, Amaonye M, Beach A, Berth K, Biswas S, Braun MC, Chen HM, Colace TV, Ganey JD, Gangopadhyay SA, Garrity R, Kasiewicz LN, Lavoie J, Madsen JA, Matsumoto Y, Mazzola AM, Nasrullah YS, Nneji J, Ren H, Sanjeev A, Shay M, Stahley MR, Fan SHY, Tam YK, Gaudelli NM, Ciaramella G, Stolz LE, Malyala P, Cheng CJ, Rajeev KG, Rohde E, Bellinger AM, Kathiresan S. Musunuru K, et al. Among authors: matsumoto y. Nature. 2021 May;593(7859):429-434. doi: 10.1038/s41586-021-03534-y. Epub 2021 May 19. Nature. 2021. PMID: 34012082
Diagnostic Accuracy of FibroScan and Factors Affecting Measurements.
Oeda S, Tanaka K, Oshima A, Matsumoto Y, Sueoka E, Takahashi H. Oeda S, et al. Among authors: matsumoto y. Diagnostics (Basel). 2020 Nov 12;10(11):940. doi: 10.3390/diagnostics10110940. Diagnostics (Basel). 2020. PMID: 33198092 Free PMC article. Review.
Genetic and chemical inhibition of IRF5 suppresses pre-existing mouse lupus-like disease.
Ban T, Kikuchi M, Sato GR, Manabe A, Tagata N, Harita K, Nishiyama A, Nishimura K, Yoshimi R, Kirino Y, Yanai H, Matsumoto Y, Suzuki S, Hihara H, Ito M, Tsukahara K, Yoshimatsu K, Yamamoto T, Taniguchi T, Nakajima H, Ito S, Tamura T. Ban T, et al. Among authors: matsumoto y. Nat Commun. 2021 Jul 19;12(1):4379. doi: 10.1038/s41467-021-24609-4. Nat Commun. 2021. PMID: 34282144 Free PMC article.
Extensive functional evaluation of exon 20 insertion mutations of EGFR.
Hirose T, Ikegami M, Endo M, Matsumoto Y, Nakashima Y, Mano H, Kohsaka S. Hirose T, et al. Among authors: matsumoto y. Lung Cancer. 2021 Feb;152:135-142. doi: 10.1016/j.lungcan.2020.12.023. Epub 2020 Dec 25. Lung Cancer. 2021. PMID: 33395611 Free article.
Efficacy and Safety of Favipiravir in Moderate COVID-19 Pneumonia Patients without Oxygen Therapy: A Randomized, Phase III Clinical Trial.
Shinkai M, Tsushima K, Tanaka S, Hagiwara E, Tarumoto N, Kawada I, Hirai Y, Fujiwara S, Komase Y, Saraya T, Koh H, Kagiyama N, Shimada M, Kanou D, Antoku S, Uchida Y, Tokue Y, Takamori M, Gon Y, Ie K, Yamazaki Y, Harada K, Miyao N, Naka T, Iwata M, Nakagawa A, Hiyama K, Ogawa Y, Shinoda M, Ota S, Hirouchi T, Terada J, Kawano S, Ogura T, Sakurai T, Matsumoto Y, Kunishima H, Kobayashi O, Iwata S. Shinkai M, et al. Among authors: matsumoto y. Infect Dis Ther. 2021 Dec;10(4):2489-2509. doi: 10.1007/s40121-021-00517-4. Epub 2021 Aug 27. Infect Dis Ther. 2021. PMID: 34453234 Free PMC article.
Staging of astrocytopathy and complement activation in neuromyelitis optica spectrum disorders.
Takai Y, Misu T, Suzuki H, Takahashi T, Okada H, Tanaka S, Okita K, Sasou S, Watanabe M, Namatame C, Matsumoto Y, Ono H, Kaneko K, Nishiyama S, Kuroda H, Nakashima I, Lassmann H, Fujihara K, Itoyama Y, Aoki M. Takai Y, et al. Among authors: matsumoto y. Brain. 2021 Sep 4;144(8):2401-2415. doi: 10.1093/brain/awab102. Brain. 2021. PMID: 33711152
Metagenome-wide association study revealed disease-specific landscape of the gut microbiome of systemic lupus erythematosus in Japanese.
Tomofuji Y, Maeda Y, Oguro-Igashira E, Kishikawa T, Yamamoto K, Sonehara K, Motooka D, Matsumoto Y, Matsuoka H, Yoshimura M, Yagita M, Nii T, Ohshima S, Nakamura S, Inohara H, Takeda K, Kumanogoh A, Okada Y. Tomofuji Y, et al. Among authors: matsumoto y. Ann Rheum Dis. 2021 Dec;80(12):1575-1583. doi: 10.1136/annrheumdis-2021-220687. Epub 2021 Aug 23. Ann Rheum Dis. 2021. PMID: 34426398 Free PMC article.
Immunotherapy for osteosarcoma.
Yahiro K, Matsumoto Y. Yahiro K, et al. Among authors: matsumoto y. Hum Vaccin Immunother. 2021 May 4;17(5):1294-1295. doi: 10.1080/21645515.2020.1824499. Epub 2020 Dec 24. Hum Vaccin Immunother. 2021. PMID: 33356848 Free PMC article.
Differential Immune-Related Microenvironment Determines Programmed Cell Death Protein-1/Programmed Death-Ligand 1 Blockade Efficacy in Patients With Advanced NSCLC.
Shirasawa M, Yoshida T, Shimoda Y, Takayanagi D, Shiraishi K, Kubo T, Mitani S, Matsumoto Y, Masuda K, Shinno Y, Okuma Y, Goto Y, Horinouchi H, Ichikawa H, Kohno T, Yamamoto N, Matsumoto S, Goto K, Watanabe SI, Ohe Y, Motoi N. Shirasawa M, et al. Among authors: matsumoto y. J Thorac Oncol. 2021 Dec;16(12):2078-2090. doi: 10.1016/j.jtho.2021.07.027. Epub 2021 Aug 20. J Thorac Oncol. 2021. PMID: 34419685
5,429 results